e-learning
resources
London 2016
Tuesday, 06.09.2016
Immune responses in the lung
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Antinuclear antibodies and rheumatoid factor are associated with blood eosinophils in asthma and COPD
Koji Tamai (Kobe, Japan), Koji Tamai, Harukazu Yoshimatsu, Toshiharu Saito, Hirofumi Matsuoka, Yasuko Koma, Nobuhiko Okada, Akiko Otsuka, Sayaka Inoue, Sachie Kume, Nao Oda, Yujiro Suzuki
Source:
International Congress 2016 – Immune responses in the lung
Session:
Immune responses in the lung
Session type:
Poster Discussion
Number:
3634
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Koji Tamai (Kobe, Japan), Koji Tamai, Harukazu Yoshimatsu, Toshiharu Saito, Hirofumi Matsuoka, Yasuko Koma, Nobuhiko Okada, Akiko Otsuka, Sayaka Inoue, Sachie Kume, Nao Oda, Yujiro Suzuki. Antinuclear antibodies and rheumatoid factor are associated with blood eosinophils in asthma and COPD. Eur Respir J 2016; 48: Suppl. 60, 3634
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016
Autoreactivity in patients with combined COPD and asthma phenotype
Source: International Congress 2014 – Novel approaches to human studies in allergy and asthma
Year: 2014
Correlation between asthma control and serum levels of IL-33 in atopic asthma
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016
Higher burden of asthma symptoms and increased blood eosinophils in ACOS
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Modulation of inflammation by benralizumab in eosinophilic airway disease
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016
Peripheral blood eosinophilia predicts lower airway eosinophilia in asthma and COPD
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
TSLP as biomarker in asthma patients
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
Levels of cytokines, sCD31 and expression of CD38 in patients with bronchial asthma of various severity out of a disease exacerbation
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014
Elevated blood eosinophil is a risk factor for future exacerbations in asthmatic children
Source: International Congress 2014 – Paediatric asthma: markers and molecules
Year: 2014
The correlation between expression of selected inflammatory mediators in induced sputum and respiratory tests in asthma and COPD
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
Increased total, secretory and NTHi-specific IgA in the COPD airway
Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice
Year: 2015
Adenovirus-specific immunoglobulin G maturation in acute exacerbations of COPD
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
IL-17A is specifically elevated in NTHi-associated AECOPD and end-stage COPD
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015
Mapping of eosinophil and basophils in COPD lung tissues
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015
Cytokine patterns and latent viruses in patients with severe asthma and COPD
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
Elevated IL-17A in very severe COPD is localized to mast cells and correlates with lung function decline
Source: International Congress 2014 – TH17 and other acute asthmatic responses
Year: 2014
Variability of total serum IgE in moderate-to-severe asthmatic patients
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Airway basophils are increased and correlated with eosinophilic inflammtaion in asthma and COPD
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Distribution of blood eosinophil in COPD patients
Source: International Congress 2014 – Lung function, COPD and inflammation
Year: 2014
Biomarkers of obesity associated with severe atopic asthma
Source: International Congress 2015 – Asthma mechanisms and management
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept